Answers are grounded in this paper and cite their sources.
Recombinant human growth hormone (rhGH) therapy in Prader-Willi syndrome (PWS) causes increased basal metabolic rate and oxygen consumption, and hence increased ventilatory load. The case of an adolescent with PWS who experienced respiratory deterioration with an increase in rhGH and improvement with cessation of therapy is reported.
No takes yet. Share an insight, caveat, or question.
Susanne Wilson (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: